REFERENCES
- Haider KM, Plager DA, Neely DE, Eikenberry J, Haggstrom A. Outpatient treatment of periocular infantile hemangiomas with oral propranolol. J AAPOS 2010;14:251–256
- Cheng JF, Gole GA, Sullivan TJ. Propranolol in the management of periorbital infantile haemangioma. Clin Experiment Ophthalmol 2010;38:547–553
- Li YC, McCahon E, Rowe NA, Martin PA, Wilcsek GA, Martin FJ. Successful treatment of infantile haemangiomas of the orbit with propranolol. Clin Experiment Ophthalmol 2010;38:554–559
- de Graaf M, Breur JM, Raphael MF, Vos M, Breugem CC, Pasmans SG. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants. J Am Acad Dermatol 2011;65:320–327
- Starkey E, Shahidullah H. Propranolol for infantile haemangiomas: a review. Arch Dis Child 2011;96:890–893
- Guo S, Ni N. Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution. Arch Ophthalmol 2010;128:255–256
- Pope E, Chakkittakandiyil A. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol 2010;146:564–565
- Hao J, Yang MB, Liu H, Li SK. Distribution of propranolol in periocular tissues: a comparison of topical and systemic administration. J Ocul Pharmacol Ther 2011;27:453–459
- Acheampong AA, Shackleton M, Tang-Liu DD, Ding S, Stern ME, Decker R. Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs. Curr Eye Res 1999;18:91–103
- File RR, Patton TF. Topically applied pilocarpine. Human pupillary response as a function of drop size. Arch Ophthalmol 1980;98:112–115
- Patton TF. Pharmacokinetic evidence for improved ophthalmic drug delivery by reduction of instilled volume. J Pharm Sci 1977;66:1058–1059
- Brown RH, Wood TS, Lynch MG, Schoenwald RD, Chien DS, Jennings LW. Improving the therapeutic index of topical phenylephrine by reducing drop volume. Ophthalmology 1987;94:847–850
- Fantes FE, Heuer DK, Parrish RK II, Sossi N, Gressel MG. Topical fluorouracil. Pharmacokinetics in normal rabbit eyes. Arch Ophthalmol 1985;103:953–955
- Anderson JA, Chen CC. Multiple dosing increases the ocular bioavailability of topically administered flurbiprofen. Arch Ophthalmol 1988;106:1107–1109
- Chrai SS, Makoid MC, Eriksen SP, Robinson JR. Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. J Pharm Sci 1974;63:333–338
- Modamio P, Lastra CF, Marino EL. A comparative in vitro study of percutaneous penetration of beta-blockers in human skin. Int J Pharm 2000;194:249–259
- Annabi B, Lachambre MP, Plouffe K, Moumdjian R, Beliveau R. Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. Pharmacol Res 2009;60:438–445
- Patton TF, Francoeur M. Ocular bioavailability and systemic loss of topically applied ophthalmic drugs. Am J Ophthalmol 1978;85:225–229
- Wallace DK, Steinkuller PG. Ocular medications in children. Clin Pediatr (Phila) 1998;37:645–652
- Urtti A, Salminen L. Minimizing systemic absorption of topically administered ophthalmic drugs. Surv Ophthalmol 1993;37:435–456
- Cheong HI, Johnson J, Cormier M, Hosseini K. In vitro cytotoxicity of eight beta-blockers in human corneal epithelial and retinal pigment epithelial cell lines: comparison with epidermal keratinocytes and dermal fibroblasts. Toxicol In Vitro 2008;22:1070–1076
- Fuchsmann C, Quintal MC, Giguere C, Ayari-Khalfallah S, Guibaud L, Powell J, et al. Propranolol as first-line treatment of head and neck hemangiomas. Arch Otolaryngol Head Neck Surg 2011;137:471–478
- Van Santvliet L, Ludwig A. Determinants of eye drop size. Surv Ophthalmol 2004;49:197–213
- Khan ZA, Boscolo E, Picard A, Psutka S, Melero-Martin JM, Bartch TC, et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 2008;118:2592–2599